|
1.
|
McManus DD, Chinali M, Saczynski JS, et
al: 30-Year trends in heart failure in patients hospitalized with
acute myocardial infarction. Am J Cardiol. 107:353–359. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Takemura G, Ohno M, Hayakawa Y, et al:
Role of apoptosis in the disappearance of infiltrated and
proliferated interstitial cells after myocardial infarction. Circ
Res. 82:1130–1138. 1998. View Article : Google Scholar
|
|
3.
|
Weidemann A and Johnson RS: Nonrenal
regulation of EPO synthesis. Kidney Int. 75:682–688. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Iwai M, Cao G, Yin W, et al:
Erythropoietin promotes neuronal replacement through
revascularization and neurogenesis after neonatal hypoxia/ischemia
in rats. Stroke. 38:2795–2803. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Matis GK and Birbilis TA: Erythropoietin
in spinal cord injury. Eur Spine J. 18:314–323. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Breggia AC, Wojchowski DM and Himmelfarb
J: JAK2/Y343/STAT5 signaling axis is required for
erythropoietin-mediated protection against ischemic injury in
primary renal tubular epithelial cells. Am J Physiol Renal Physiol.
295:F1689–F1695. 2008. View Article : Google Scholar
|
|
7.
|
Xu X, Cao Z, Cao B, et al: Carbamylated
erythropoietin protects the myocardium from acute
ischemia/reperfusion injury through a PI3K/AKT-dependent mechanism.
Surgery. 146:506–514. 2009. View Article : Google Scholar
|
|
8.
|
Van der Putten K, Jie KE, Emans ME, et al:
Erythropoietin treatment in patients with combined heart and renal
failure: objectives and design of the EPOCARES study. J Nephrol.
23:363–368. 2010.PubMed/NCBI
|
|
9.
|
Latini R, Brines M and Fiordaliso F: Do
non-hemopoietic effects of erythropoietin play a beneficial role in
heart failure? Heart Fail Rev. 13:415–423. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Liu G, Sun Y, Li Z, et al: Apoptosis
induced by endoplasmic reticulum stress involved in diabetic kidney
disease. Biochem Biophys Res Commun. 370:651–656. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Liu XH, Zhang ZY, Sun S, et al: Ischemic
postconditioning protects myocardium from ischemia/reperfusion
injury through attenuating endoplasmic reticulum stress. Shock.
30:422–427. 2008. View Article : Google Scholar
|
|
12.
|
Hiroi T, Wei H, Hough C, et al: Protracted
lithium treatment protects against the ER stress elicited by
thapsigargin in rat PC12 cells: roles of intracellular calcium,
GRP78 and Bcl-2. Pharmacogenomics J. 5:102–111. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Janssen K, Horn S, Niemann MT, et al:
Inhibition of the ER Ca2+ pump forces multidrug-resistant cells
deficient in Bak and Bax into necrosis. J Cell Sci. 122:4481–4491.
2009.
|
|
14.
|
Ali BR: Is cystic fibrosis-related
diabetes an apoptotic consequence of ER stress in pancreatic cells?
Med Hypotheses. 72:55–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Salminen A, Kauppinen A, Suuronen T, et
al: ER stress in Alzheimer's disease: a novel neuronal trigger for
inflammation and Alzheimer's pathology. J Neuroinflammation.
6:412009.
|
|
16.
|
Arduino DM, Esteves AR, Cardoso SM, et al:
Endoplasmic reticulum and mitochondria interplay mediates apoptotic
cell death: relevance to Parkinson's disease. Neurochem Int.
55:341–348. 2009.PubMed/NCBI
|
|
17.
|
Xin W, Li X, Lu X, et al: Involvement of
endoplasmic reticulum stress-associated apoptosis in a heart
failure model induced by chronic myocardial ischemia. Int J Mol
Med. 27:503–509. 2011.PubMed/NCBI
|
|
18.
|
Kumar S, Kasseckert S, Kostin S, et al:
Ischemic acidosis causes apoptosis in coronary endothelial cells
through activation of caspase-12. Cardiovasc Res. 73:172–180. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Yada T, Shimokawa H, Hiramatsu O, et al:
Erythropoietin enhances hydrogen peroxide-mediated dilatation of
canine coronary collateral arterioles during myocardial ischemia in
dogs in vivo. Am J Physiol Heart Circ Physiol. 299:H1928–H1935.
2010. View Article : Google Scholar
|
|
20.
|
Hirata A, Minamino T, Asanuma H, et al:
Erythropoietin just before reperfusion reduces both lethal
arrhythmias and infarct size via the phosphatidylinositol-3
kinase-dependent pathway in canine hearts. Cardiovasc Drugs Ther.
19:33–40. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Shi Z, Hodges VM, Dunlop EA, et al:
Erythropoietin-induced activation of the JAK2/STAT5, PI3K/AKT, AND
RAS/ERK pathways promotes malignant cell behavior in a modified
breast cancer cell line. Mol Cancer Res. 8:615–626. 2010.
View Article : Google Scholar : PubMed/NCBI
|
